Trade BioArctic AB ser. B - BIOA B CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 1.9
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investmentSEK 1,000.00Overnight funding adjustmentCharges from full value of position-0.015665 %(-SEK 3.13)Trade size with leverage ~ SEK 20,000.00Money from leverage ~ SEK 19,000.00Go to platform: -0.01566%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investmentSEK 1,000.00Overnight funding adjustmentCharges from full value of position-0.006558 %(-SEK 1.31)Trade size with leverage ~ SEK 20,000.00Money from leverage ~ SEK 19,000.00Go to platform: -0.00656%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: SEK
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: Sweden
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: SEK 1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.015665 %
  (-SEK 3.13)

• Margin. Your investment: SEK 1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.006558 %
  (-SEK 1.31)

Key Stats

• Prev. Close: 307.45
• Open: 305.25
• 1-Year Change: 51.75%
• Day's Range: 300.05 - 308.25

Trade BioArctic AB ser. B - BIOA B

What is BioArctic AB (BIOA B)?

BioArctic AB is a biopharmaceutical company focused on the development of treatments for neurodegenerative diseases and central nervous system disorders. The company engages in research and development activities targeting conditions such as Alzheimer's disease and Parkinson's disease. BioArctic's pipeline includes therapeutic antibodies and other biologics designed to modify disease progression. The company collaborates with academic institutions and pharmaceutical partners to advance its clinical programs. BioArctic operates with an emphasis on innovation in neuroscience and aims to address unmet medical needs through novel therapeutic approaches. Its work contributes to the broader field of neurodegenerative disease research.

BioArctic AB Stock Price Today: Live Overview

The price today is shaped by market fluctuations seen in BioArctic AB, currently trading at kr309.35. The price has moved within a daily range of kr298.45 to kr308.25, showing a daily percentage change of -0.2604%.

FAQ: BioArctic AB (BIOA B)

What is the current price of BIOA B stock?

The current price is kr309.35.

Does BIOA B pay dividends?

Dividends are paid via cash distributions (if applicable).

Does BIOA B have a formal corporate presence or regional headquarters in the UAE?

BioArctic AB does not have an official regional office or subsidiary in the UAE and operates via partners.

What is BIOA B best known for?

The company is most famous for its biopharmaceutical research and development in neurodegenerative diseases.

What assets are typically shown together with BIOA B?

Commonly shown alongside BIOA B: L&G Europe ex UK Equity UCITS ETF, Extreme Networks Inc, Medical Developments International